Judith Thijs
0000-0003-2753-5235
6 papers found
Refreshing results…
EASI p‐EASI: predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers
Two‐year drug survival of dupilumab in a large cohort of difficult‐to‐treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry
Dupilumab is very effective in a large cohort of difficult‐to‐treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry
Biomarkers detected in dried blood spots from atopic dermatitis patients strongly correlate with disease severity
EASI p‐ EASI : Predicting disease severity in atopic dermatitis patients treated with cyclosporin A
EASI p-EASI: Utilizing a combination of serum biomarkers offers an objective measurement tool for disease severity in atopic dermatitis patients
Missing publications? Search for publications with a matching author name.